Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07158801 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Project EMPOWER-OCD

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Sep 2026 → Feb 2027
See other at-risk trials from Boston University Charles River Campus

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 2 entries
    • Primary and study completion pushed from Sep 2026 to Feb 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 2 of 3 entries
  2. Phase: Phase 1 to Not applicablev3 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Aug 31, 2026 to Sep 2026
    • Study completion date: Aug 31, 2027 to Sep 2026
    • Start date changed from estimate of Oct 1, 2025 to Mar 25, 2025
    • Site details revised
  3. Study description shortened, about 38 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research study aims to adapt and evaluate the acceptability and effectiveness of Project EMPOWER-OCD for socioeconomically diverse caregivers of patients with OCD. Designed to reduce obstacles (e.g. months long time commitment, high cost, transportation) to treatment that caregivers may be particularly prone to, project EMPOWER-OCD will provide targeted intervention of accommodation - a well-established, potentially modifiable risk factor for child anxiety, OCD, and its related disorders - in a single, self-guided session via an online format.
Trial Details
NCT Number NCT07158801
Lead Sponsor Boston University Charles River Campus
Conditions
(from sponsor)		 Obsessive-Compulsive Disorder
Related terms Obsessive-Compulsive Disorder
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov